Resona Asset Management’s Bristol-Myers Squibb BMY Stock Holding History

Resona Asset Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36M	Sell	622,880 -41,194	-6%	-$2.37M	0.17%	107
2026 Q1	$40.2M	Sell	664,074 -5,292	-0.8%	-$308K	0.2%	100
2025 Q4	$36.1M	Sell	669,366 -21,761	-3%	-$1.05M	0.17%	105
2025 Q3	$31.1M	Sell	691,127 -46,004	-6%	-$2.15M	0.15%	130
2025 Q2	$34.1M	Buy	737,131 +42,772	+6%	+$2.1M	0.17%	119
2025 Q1	$42.2M	Buy	694,359 +38,040	+6%	+$2.22M	0.24%	88
2024 Q4	$37.2M	Sell	656,319 -38,360	-6%	-$2.14M	0.22%	86
2024 Q3	$35.9M	Sell	694,679 -9,678	-1%	-$454K	0.21%	97
2024 Q2	$29.3M	Sell	704,357 -71,209	-9%	-$3.19M	0.18%	113
2024 Q1	$42.1M	Buy	+775,566	New	+$39.5M	0.25%	83

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Resona Asset Management's BMY Position: Q2 2026 in Review

Resona Asset Management reduced its Bristol-Myers Squibb (BMY) stake by 6.2% in Q2 2026, selling an estimated $2.37M and leaving 622,880 shares worth $36M. The position accounts for 0.17% of the portfolio, ranked #107.

Resona Asset Management first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $42.2M in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Resona Asset Management held 622,880 shares of Bristol-Myers Squibb worth $36M as of Q2 2026.
Resona Asset Management sold 41,194 Bristol-Myers Squibb shares in Q2 2026, an estimated $2.37M.
Bristol-Myers Squibb made up 0.17% of Resona Asset Management's portfolio in Q2 2026, its #107 holding.
Resona Asset Management first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
Resona Asset Management's Bristol-Myers Squibb position peaked at $42.2M in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Resona Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.